Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Sends Expression System for Beta Testing; Announces Exec s Departure

NEW YORK, March 15 – Nanogen said Thursday it had shipped a new system designed for targeted gene expression applications for beta testing at two undisclosed US institutions and one in Europe.

Nanogen plans to use the results of the tests to develop new applications for detecting gene expression. Currently the company’s NanoChip system is primarily used do detect and analyze SNPs, short tandem repeats, and mutations.

Nanogen said that its system would differ from most commercial gene expression techniques by allowing researchers to get quantitative, reproducible assays with a known set of genes.

“These scientists will be looking for the capability to perform time-series studies with multiple samples on a single chip or across multiple chips,” Nanogen said in a statement.

Nanogen also said that it had upgraded the loader of its NanoChip system so that it can handle either a 384 or a 96 well plate. 

In addition, Nanogen announced that George Bers, vice president of Business Development, left the company to take a job in the Bioresearch Division of Beckman Coulter.

Nanogen did not announce a replacement.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.